Krystal Biotech, Inc.
KRYS
DELAYED 1 MONTH

9 insider filings · Latest: Jun 4, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 4, 2026Jun 5 10:40 PMSuma KrishnanDirector, President, R&D, 10% Owner
Sale
25,000$308.11$7.7M1,378,155(D)

View →

Jun 4, 2026Jun 5 10:38 PMKrish S KrishnanDirector, President and CEO, 10% Owner
Sale
25,000$308.12$7.7M1,450,253(D)

View →

May 26, 2026May 27 9:17 PMJohn Charles ThomasEVP, General Counsel
Sale
642$302.03$193.9K0(D)

View →

Mar 4, 2026Mar 6 11:23 PMKrishnan SumaDirector, President, R&D, 10% Owner
Sale
25,000$263.21$6.6M1,403,155(D)

View →

Mar 4, 2026Mar 6 11:22 PMKrishnan Krish SDirector, President and CEO, 10% Owner
Sale
25,000$263.17$6.6M1,475,253(D)

View →

Mar 2, 2026Mar 3 11:33 PMKathryn RomanoChief Accounting Officer
Sale
750$267.60$200.7K22,366(D)

View →

Feb 27, 2026Mar 3 11:28 PMDaniel JanneyDirector
Sale
11,803$275.59$3.3M73,293(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Feb 27, 2026Mar 3 11:33 PMKathryn RomanoChief Accounting Officer
Grant/Award
19,017$275.645,442(D)

View →

Feb 27, 2026Mar 3 11:33 PMKathryn RomanoChief Accounting Officer
Option Exercise
8,050—1,650(D)

View →

Feb 27, 2026Mar 3 11:33 PMKrishnan SumaDirector, President, R&D, 10% Owner
Grant/Award
68,892$275.6443,536(D)

View →

Feb 27, 2026Mar 3 11:33 PMKrishnan SumaDirector, President, R&D, 10% Owner
Option Exercise
26,500—12,000(D)

View →

Feb 27, 2026Mar 3 11:30 PMKrishnan Krish SDirector, President and CEO, 10% Owner
Grant/Award
63,389$275.6418,140(D)

View →

Feb 27, 2026Mar 3 11:30 PMKrishnan Krish SDirector, President and CEO, 10% Owner
Option Exercise
40,725—17,175(D)

View →